Advertisement
Screener

Nuvation Bio Inc. (NUVB) ROA

Nuvation Bio Inc. (NUVB) ROA

  • 2026-06-30: ROA -20.12%.
  • 2026-03-31: ROA -23.92%.
  • 2025-12-31: ROA -34.40%.
  • 2025-09-30: ROA -36.15%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-20.12%
2026-03-31-23.92%
2025-12-31-34.40%
2025-09-30-36.15%
2025-06-30-31.35%
2025-03-31-123.13%
2024-12-31-105.05%
2024-09-30-93.12%
2024-06-30-85.86%
2024-03-31-11.23%
2023-12-31-12.20%
2023-09-30-13.13%
2023-06-30-14.10%
2023-03-31-15.92%
2022-12-31-15.50%
2022-09-30-15.80%
2022-06-30-14.35%
2022-03-31-11.67%
2021-12-31-11.19%
2021-09-30-9.40%
2021-06-30-7.87%
2021-03-31-6.41%
2020-12-31-18.78%

Annual ROA

DateROA
2025-12-31-34.40%
2024-12-31-105.05%
2023-12-31-12.20%
2022-12-31-15.50%
2021-12-31-11.19%
2020-12-31-18.78%

Similar stocks

Stock NameCountryMarket CapPE Ratio
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Biohaven Ltd. (BHVN)United States$1.990B-3.83
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Generate Biomedicines, Inc. (GENB)United States$2.052B
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B